Drug Name: | Sparfloxacin (110871-86-8) |
---|---|
PubChem ID: | 60464 |
SMILES: | C[C@@H]1CN(C[C@@H](N1)C)C2=C(C3=C(C(=C2F)N)C(=O)C(=CN3C4CC4)C(=O)O)F |
InchiKey: | DZZWHBIBMUVIIW-DTORHVGOSA-N |
Therapeutic Category: |
Molecular Weight (dalton) | : | 392.406 |
LogP | : | 2.0816 |
Ring Count | : | 2 |
Hydrogen Bond Acceptor Count | : | 6 |
Hydrogen Bond Donor Count | : | 3 |
Total Polar Surface Area | : | 100.59 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|---|---|---|---|
Amiodarone (1951-25-3) | Torsade De Pointes | Additive | Not established | Overview of electrocardiographic and cardiovascular safety data for sparfloxacin Sparfloxacin Safety Group |
Terfenadine (50679-08-8) | Torsade De Pointes | Additives | Additive effect of drug | The effect of terfenadine on the cardiac pharmacodynamics of sparfloxacin |
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category
Toxicity | Source |
---|